Sucampo Pharmaceuticals, Inc. company info

CIK 1365216
IRS Number 133929237
State of incorporation None
Business address 805 KING FARM BOULEVARD, SUITE 550
Mail address 805 KING FARM BOULEVARD, SUITE 550

Short summary

Sucampo Pharmaceuticals, Inc. is a Maryland company, with head office located at 805 King Farm Boulevard, Suite 550 Rockville, Maryland 20850. In 2017 the company owned a total of 388.14 million USD worth of assets, including 190.06 million USD worth of current assets. 2015 was the year when the company amassed the most assets.

Sucampo Pharmaceuticals, Inc. Income Statement

Name [in Millions USD]2008200920102011201220132014201520162017Trends
Gross Profit 61.8754.7678.46
Research and development 32.9123.9633.5021.2921.5220.5733.6346.62
Operating Income (Loss) 9.42-0.15-17.698.329.2027.2344.4653.88
Interest expense 0.082.462.351.891.526.8523.76
Other Nonoperating Income (Expense) -0.52-3.70-2.021.833.521.255.89-1.77
Income Tax Expense (Benefit) 5.08-0.57-4.612.923.9314.0110.30-4.11
Net income 4.78-2.76-17.315.067.0213.1333.3718.49

Sucampo Pharmaceuticals, Inc. Balance Sheet

Name [in Millions USD]2008200920102011201220132014201520162017Trends
Cash and cash equivalents 93.7058.0152.2861.6947.2953.5371.34127.9884.7375.04
Accounts Receivable, Net, Current 0.730.613.624.765.3418.1719.8133.10
Inventories 4.870.42021.5723.1024.18
Deferred income taxes
Property, Plant and Equipment, Gross 4.114.514.534.519.979.94
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 2.452.973.383.753.583.73
Goodwill 071.8473.0273.02
Intangible Assets, Net (Excluding Goodwill) 3.077.906.935.950.150.14
Other Assets, Noncurrent 9.220.970.660.550.310.770.800.80
Total assets 145.60124.94135.35142.24141.57469.74365.08388.14
Current assets 129.95105.11108.11119.35121.85237.70165.14190.06
Accounts payable 4.185.355.655.624.146.1711.176.25
Taxes Payable, Current 4.940.
Total current liabilities 46.7338.4847.0242.5233.8155.6432.1137.18
Deferred Revenue, Noncurrent 7.696.726.525.825.120.942.782.63
Deferred income taxes 1.772.421.220.8268.573.007.35
Other Accrued Liabilities, Noncurrent 0.420.42
Total liabilities 103.7989.3186.9772.8759.26345.98338.74348.51
Common Stock, Value, Issued 0.420.42
Retained Earnings (Accumulated Deficit) -37.56-41.68-31.13-24.49-13.7314.75-151.74-141.37
Accumulated Other Comprehensive Income (Loss), Net of Tax 19.8616.2616.0015.3614.4349.6954.4354.46

Sucampo Pharmaceuticals, Inc. Cash Flow

Name [in Millions USD]2008200920102011201220132014201520162017Trends
Net income 4.78-2.76-17.315.067.0213.1333.3718.49
Depreciation and amortization 0.790.961.311.491.491.0910.5845.68
Depreciation 0.600.590.540.510.420.640.90
Amortization of Intangible Assets 0.340.340.3410.643.7025.68
Deferred Income Tax Expense (Benefit) 0.01-0.1026.230.78-1.700.54-9.89-35.32
Accounts receivable -
Inventories 0.13-0.090.16-0.211.441.23
Accounts payable 1.680.892.87-1.452.24-3.44-1.72-2.77
Deferred revenue -4.56-6.53-1.94-0.10-3.13-0.19-5.350.36
Net Cash Provided by (Used in) Operating Activities 4.97-3.35-19.9912-4.2130.8818.59
Payments to Acquire Property, Plant, and Equipment 0.500.330.280.440.170.073.561.23
Payments to Acquire Businesses, Net of Cash Acquired 28.12161.19
Payments to Acquire Intangible Assets 2.9233
Net Cash Provided by (Used in) Investing Activities -35.46-11.8627.90-0.59-12.6212.96-131.15
Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12.96-131.15-1.84
Proceeds from Stock Plans
Proceeds from Issuance of Common Stock 5.285.33
Payments for Repurchase of Common Stock 0.701.280.3443.96
Net Cash Provided by (Used in) Financing Activities -2.85-1.64-8.08-8.4510.58-15.41149.34
Cash and Cash Equivalents, Period Increase (Decrease) -32.28-12.181.421.36-7.9227.5236.6690.02